Growth Hormone and Heart Failure
Modifications of the Growth Hormone/IGF1 Axis in Heart Failure Patients
1 other identifier
observational
180
0 countries
N/A
Brief Summary
Heart failure induces modification in several neurohormonal systems. The aim of this study is to determine if the growth hormone/IGF1 axis is modified in heart failure patients compared to healthy volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2000
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2000
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2003
CompletedFirst Submitted
Initial submission to the registry
September 14, 2005
CompletedFirst Posted
Study publicly available on registry
September 19, 2005
CompletedSeptember 19, 2005
April 1, 2002
September 14, 2005
September 14, 2005
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Heart failure patients in stable condition
You may not qualify if:
- cancer
- pituitary disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Maison, MD, PhD
APHP
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 14, 2005
First Posted
September 19, 2005
Study Start
September 1, 2000
Study Completion
February 1, 2003
Last Updated
September 19, 2005
Record last verified: 2002-04